Follow
Maria Isabel Ofelia Behrens
Maria Isabel Ofelia Behrens
Profesor Titular Neurologia Hospital Clinico Universidad de Chile
Verified email at uchile.cl
Title
Cited by
Cited by
Year
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
A Ramirez, A Heimbach, J Gründemann, B Stiller, D Hampshire, LP Cid, ...
Nature genetics 38 (10), 1184-1191, 2006
14382006
Cancer linked to Alzheimer disease but not vascular dementia
CM Roe, AL Fitzpatrick, C Xiong, W Sieh, L Kuller, JP Miller, MM Williams, ...
Neurology 74 (2), 106-112, 2010
3272010
Alzheimer disease and cancer
CM Roe, MI Behrens, C Xiong, JP Miller, JC Morris
Neurology 64 (5), 895-898, 2005
2432005
HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin‐positive, tau‐negative inclusions caused by a missense mutation in the signal peptide of progranulin
O Mukherjee, P Pastor, NJ Cairns, S Chakraverty, JSK Kauwe, S Shears, ...
Annals of Neurology: Official Journal of the American Neurological …, 2006
2202006
The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families.
C RF, H M, F RA, F S, K E, T C, C R, L C, P G, H C, K K, M A, W M, B F, ...
Nature Genetics 11 (2), 219-222, 1995
2201995
A common biological mechanism in cancer and Alzheimer's disease?
MI Behrens, C Lendon, CM Roe
Current Alzheimer Research 6 (3), 196-204, 2009
2162009
3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons
MI Behrens, J Koh, LMT Canzoniero, SL Sensi, CA Csernansky, DW Choi
Neuroreport 6 (3), 545-548, 1995
1321995
Clinical spectrum of Kufor‐Rakeb syndrome in the Chilean kindred with ATP13A2 mutations
MI Behrens, N Brüggemann, P Chana, P Venegas, M Kägi, T Parrao, ...
Movement Disorders 25 (12), 1929-1937, 2010
1262010
Susceptibility to apoptosis is enhanced in immature cortical neurons
JW McDonald, MI Behrens, C Chung, T Bhattacharyya, DW Choi
Brain research 759 (2), 228-232, 1997
1241997
Validation of the Spanish-language version of the Montreal Cognitive Assessment test in adults older than 60 years
C Delgado, A Araneda, MI Behrens
Neurología (English Edition) 34 (6), 376-385, 2019
1192019
E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.
L CL, M A, B IM, K KS, M L, N J, N R, M A, B F, W M, A M, A Viana JC, O J, ...
Human Mutation 10 (3), 186-195, 1997
1161997
The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-β peptide but not aggregated, cytotoxic amyloid-β peptide
K Boland, M Behrens, D Choi, K Manias, DH Perlmutter
Journal of Biological Chemistry 271 (30), 18032-18044, 1996
1141996
Ischemia enhances activation by Ca2+ and redox modification of ryanodine receptor channels from rat brain cortex
R Bull, JP Finkelstein, J Gálvez, G Sánchez, P Donoso, MI Behrens, ...
Journal of Neuroscience 28 (38), 9463-9472, 2008
1112008
Possible role of apamin‐sensitive K+ channels in myotonic dystrophy
MI Behrens, P Jalil, A Serani, F Vergara, O Alvarez
Muscle & Nerve: Official Journal of the American Association of …, 1994
1031994
Redox regulation of RyR-mediated Ca2+ release in muscle and neurons
C Hidalgo, R Bull, MI Behrens, P Donoso
Biological research 37 (4), 539-552, 2004
992004
Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype
N Brüggemann, J Hagenah, K Reetz, A Schmidt, M Kasten, I Buchmann, ...
Archives of neurology 67 (11), 1357-1363, 2010
932010
Nonmotor symptoms in genetic Parkinson disease
M Kasten, L Kertelge, N Brüggemann, J Van Der Vegt, A Schmidt, V Tadic, ...
Archives of neurology 67 (6), 670-676, 2010
912010
Validación del instrumento Montreal Cognitive Assessment en espańol en adultos mayores de 60 ańos
C Delgado, A Araneda, MI Behrens
Neurología 34 (6), 376-385, 2019
902019
ATP13A2 variants in early‐onset Parkinson's disease patients and controls
A Djarmati, J Hagenah, K Reetz, S Winkler, MI Behrens, H Pawlack, ...
Movement disorders: official journal of the Movement Disorder Society 24 (14 …, 2009
852009
Nicotinamide, a poly [ADP-ribose] polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of Alzheimer’s disease
F Salech, DP Ponce, AC Paula-Lima, CD SanMartin, MI Behrens
Frontiers in Aging Neuroscience 12, 255, 2020
742020
The system can't perform the operation now. Try again later.
Articles 1–20